Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder

NCT01447576 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1036

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: ADT
DRUG: OPC-34712

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.